ATXS icon

Astria Therapeutics

76 hedge funds and large institutions have $205M invested in Astria Therapeutics in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 19 increasing their positions, 18 reducing their positions, and 16 closing their positions.

Holders
76
Holders Change
+11
Holders Change %
+16.92%
% of All Funds
1.2%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.02%
New
27
Increased
19
Reduced
18
Closed
16
Calls
$188K
Puts
$187K
Net Calls
+$1K
Net Calls Change
-$197K
Name Market Value Shares Shares
Change
Shares
Change %
SWA
76
SOA Wealth Advisors
New York
$58 7
Balyasny Asset Management
77
Balyasny Asset Management
Illinois
-485,939 Closed
SCM
78
Silverarc Capital Management
Massachusetts
-93,823 Closed
EI
79
EAM Investors
California
-72,129 Closed
CCIA
80
Campbell & Co Investment Adviser
Maryland
-40,202 Closed
Qube Research & Technologies (QRT)
81
Qube Research & Technologies (QRT)
United Kingdom
-34,068 Closed
Marshall Wace
82
Marshall Wace
United Kingdom
-30,994 Closed
MFS
83
Mirabella Financial Services
United Kingdom
-28,585 Closed
CSS
84
Cubist Systematic Strategies
Connecticut
-17,363 Closed
Verition Fund Management
85
Verition Fund Management
Connecticut
-16,794 Closed
DC
86
Diametric Capital
Massachusetts
-10,859 Closed
LP
87
LMR Partners
United Kingdom
-10,341 Closed
PMEF
88
Point72 Middle East FZE
United Arab Emirates
-2,866 Closed
DWA
89
Dorsey Wright & Associates
California
-2,042 Closed
BFEC
90
Benjamin F. Edwards & Company
Missouri
-333 Closed
ME
91
McIlrath & Eck
Washington
-83 Closed
ASN
92
Advisory Services Network
Georgia
-41 Closed
CFGS
93
Concourse Financial Group Securities
Alabama
Group One Trading
94
Group One Trading
Illinois
Man Group
95
Man Group
United Kingdom